Euroopa Liit - eesti - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformiin vesinikkloriid - suhkurtõbi, tüüp 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Euroopa Liit - eesti - EMA (European Medicines Agency)

alexion europe sas - eculizumab - hemoglobinuuria, paroksüsmaalne - immunosupressandid - soliris on näidatud täiskasvanute ja laste raviks:paroxysmal öise haemoglobinuria (pnh). tõendeid kliinilise kasu on näidanud patsientidel haemolysis kliiniliste sümptomite(s) soovituslik kõrge haiguse aktiivsusega, sõltumata sellest, vereülekande ajalugu (vt lõik 5. ebatüüpiline hemolüütilis-ureemilise sündroomi (ahus). soliris on näidustatud täiskasvanute raviks:tulekindlad generaliseerunud myasthenia gravis (gmg) patsientidel, kes on anti-atsetüülkoliin retseptori (achr) antikeha-positiivsete (vt lõik 5. neuromyelitis optica spectrum disorder (nmosd) patsientidel, kes on anti-aquaporin-4 (aqp4) antikeha-positiivsete koos relapsing haiguse kulg.

Eesti - eesti - Ravimiamet

teva pharma b.v. - bikalutamiid - õhukese polümeerikattega tablett - 50mg 30tk; 50mg 60tk; 50mg 100tk; 50mg 40tk; 50mg 50tk; 50mg 28tk; 50mg 84tk; 50mg 90tk; 50mg 56tk

Eesti - eesti - Ravimiamet

actavis group ptc ehf. - bikalutamiid - õhukese polümeerikattega tablett - 150mg 40tk; 150mg 140tk; 150mg 7tk; 150mg 280tk; 150mg 200tk; 150mg 90tk; 150mg 28tk; 150mg 5tk; 150mg 98tk

Eesti - eesti - Ravimiamet

accord healthcare b.v. - bikalutamiid - õhukese polümeerikattega tablett - 50mg 100tk; 50mg 30tk; 50mg 98tk; 50mg 20tk; 50mg 14tk; 50mg 84tk; 50mg 90tk; 50mg 28tk; 50mg 60tk

Eesti - eesti - Ravimiamet

teva pharma b.v. - bikalutamiid - õhukese polümeerikattega tablett - 150mg 30tk; 150mg 84tk; 150mg 56tk; 150mg 40tk; 150mg 20tk; 150mg 100tk; 150mg 28tk; 150mg 90tk

Eesti - eesti - Ravimiamet

accord healthcare b.v. - bikalutamiid - õhukese polümeerikattega tablett - 150mg 28tk; 150mg 90tk; 150mg 60tk; 150mg 30tk; 150mg 7tk; 150mg 100tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

glaxosmithkline (ireland) limited - niraparib (tosilate monohydrate) - fallopian tube neoplasms; peritoneal neoplasms; ovarian neoplasms - antineoplastilised ained - zejula is indicated: , as monotherapy for the maintenance treatment of adult patients with advanced epithelial (figo stages iii and iv) high-grade ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy. , as monotherapy for the maintenance treatment of adult patients with platinum sensitive relapsed high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum based chemotherapy.

Eesti - eesti - Ravimiamet

accord healthcare b.v. - esetimiib - tablett - 10mg 100tk; 10mg 10tk; 10mg 14tk; 10mg 300tk; 10mg 50tk; 10mg 7tk; 10mg 98tk; 10mg 30tk; 10mg 28tk

Eesti - eesti - Ravimiamet

pharmaswiss ceska republika s.r.o. - esetimiib - tablett - 10mg 10tk; 10mg 28tk; 10mg 20tk; 10mg 84tk; 10mg 50tk; 10mg 30tk; 10mg 300tk; 10mg 90tk; 10mg 98tk